Lipigon Pharmaceuticals AB (publ) (FRA:9RP)

Germany · Delayed Price · Currency is EUR

0.0010

0.00 (0.00%)

Feb 20, 2026, 12:26 PM EST

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharmaceuticals	10.29M	16.41M		2.21M	4.01M	1.74M
Pharmaceuticals Growth	-37.30%	-		-44.86%	130.20%	50701.98%
Total	10.29M	16.41M		2.21M	4.01M	1.74M
Total Growth	-37.30%	-		-44.86%	130.20%	50701.98%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Sweden	10.29M	16.41M		2.21M	4.01M	1.74M
Sweden Growth	-37.30%	-		-44.86%	130.20%	50701.98%
Total	10.29M	16.41M		2.21M	4.01M	1.74M
Total Growth	-37.30%	-		-44.86%	130.20%	50701.98%

Source: S&P Global Market Intelligence.